Bearing in mind that a competitive inhibition may be overridden by increased substrate concentrations, Gao et al. developed a series of benzothiazinone uncompetitive (allosteric) GSK3β inhibitors, the majority of which expressed moderate antiproliferative activity on ovarian cancer cell lines. Here, GSK3B is linked to ovarian cancer.